Rhythm Pharmaceuticals Inc header image

Rhythm Pharmaceuticals Inc

RYTM

Equity

ISIN null / Valor 25337263

NASDAQ (2026-08-06)
USD 112.10+1.26%

Rhythm Pharmaceuticals Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Rhythm Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare genetic disorders of obesity, specifically those related to the melanocortin-4 receptor (MC4R) pathway. These disorders are distinct from general obesity and are characterized by early-onset, severe obesity and hyperphagia, a condition marked by an insatiable hunger. The company's primary focus is on addressing these rare MC4R pathway impairments to provide targeted therapeutic solutions for patients suffering from these debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

24.5%1Y
359%3Y
701%5Y

Performance

45.2%1Y
54.9%3Y
74.2%5Y

Volatility

Market cap

7718 M

Market cap (USD)

Daily traded volume (Shares)

944,321

Daily traded volume (Shares)

1 day high/low

56.78 / 55.07

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
5.00
Nature:
starstarstarstarstar
2.00
Adrian Pusz
Switzerland, 20 Apr 2025
star star star star star
Rhythm develops what will always be needed - rare disease therapies

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%USD 82.80
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 5,608.45
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 1,836.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%INR 834.60
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%INR 1,883.80
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%INR 562.55
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.54%INR 439.85
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%INR 2,617.50
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22